Cambrex predicts flat generic API sales for 2016

Cambrex to start work on Pharma 4 API site in 2016

By Gareth Macdonald

Cambrex has said it will invest around $20m in its Pharma 4 API facility before the end of the year in an effort to get ahead of the capacity utilisation curve.


Patheon will list on NYSE today

By Gareth Macdonald

API and drug maker Patheon will begin trading on the New York Stock Exchange under the symbol PTHN later today.